title: Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
authors.forename: G
authors.initials: G
authors.lastname: Vreugdenhil
authors.forename: A
authors.initials: A
authors.lastname: Schattenberg
authors.forename: E C
authors.initials: EC
authors.lastname: Dompeling
authors.forename: A J
authors.initials: AJ
authors.lastname: Swaak
authors.forename: T
authors.initials: T
authors.lastname: De Witte
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000503:physiopathology* / Q000517:prevention & control; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery; D008727:Methotrexate / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D016572:Cyclosporine; D011239:Prednisolone; D002955:Leucovorin; D008727:Methotrexate